Australia markets closed

Prescient Therapeutics Limited (PTX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0520-0.0060 (-10.34%)
At close: 04:10PM AEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-4.429
-2.314
-
Purchases of investments
-16,000
-16,000
-
-
-
Net cash used for investing activities
-16,000
-16,000
-4.429
-2.314
-
Cash flows from financing activities
Debt repayment
-
-
-165.829
8.949
-
Common stock issued
16,526
16,526
594.122
13,577
-
Common stock repurchased
-
-
-
-836.552
-
Other financing activities
-697.818
-697.818
-
-
-
Net cash used provided by (used for) financing activities
15,828
15,828
428.293
12,750
-
Net change in cash
-6,363
-6,363
-3,889
8,777
-2,317
Cash at beginning of period
12,264
12,264
16,098
7,357
9,640
Cash at end of period
5,895
5,895
12,264
16,098
7,357
Free cash flow
Capital expenditure
-
-
-4.429
-2.314
-
Free cash flow
-6,191
-6,191
-4,317
-3,972
-2,317